DNTH — Dianthus Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.17bn
- $3.28bn
- $2.04m
U.S. STOCKS ON THE MOVE-Waldencast, Danaher, Asset Entities
Dianthus Therapeutics extends rally after boosted $251 mln equity raise
Brief: Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering
U.S. STOCKS ON THE MOVE-Anavex Life Sciences, Oil companies, Yum! Brands
Dianthus Therapeutics surges again ahead of planned equity raise
Brief: Dianthus Therapeutics Announces Proposed $150 Million Underwritten Public Offering
Dianthus Therapeutics launches $150 mln equity offering after shares surge
U.S. STOCKS ON THE MOVE-Sanofi SA, Nutanix, Bullish
Dianthus surges after mid-stage trial win for muscle-weakening drug
U.S. STOCKS ON THE MOVE-New Fortress Energy, Pulse Biosciences, US telecom stocks
U.S. STOCKS ON THE MOVE-Veeva, Gold miners, Ideaya Biosciences
Brief: Dianthus Therapeutics Announces Positive Data For Claseprubart From The Phase 2 Magic Trial In Generalized Myasthenia Gravis
Dianthus Therapeutics rises after mid-stage trial win for muscle-weakening drug
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial
U.S. STOCKS ON THE MOVE-Tesla, ABM Industries, Regeneron
Dianthus Therapeutics rises after William Blair starts coverage with 'outperform'
Dianthus Therapeutics Inc expected to post a loss of 85 cents a share - Earnings Preview